Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • News
  • Podcast
  • Jetstream
  • Contact
Select Page
Wave Health Named a 2024 ASCO Breakthrough Abstract Award Winner

Wave Health Named a 2024 ASCO Breakthrough Abstract Award Winner

by Tiffany Youtchoko | Jul 17, 2024 | Portfolio Company News

Origionally posted on TTI’s website: https://tti.care/2024-asco-breakthrough-abstract-award-winner/   Recognized by Conquer Cancer®, the ASCO® Foundation, and the 2024 ASCO® Breakthrough Program Committee, Prestigious Award Recognizes Top Scoring Study...
Novel Study to Assess Wave Health For Stem Cell Transplant Patients Delivers Promising Results and Valuable Real-World Data

Novel Study to Assess Wave Health For Stem Cell Transplant Patients Delivers Promising Results and Valuable Real-World Data

by Tiffany Youtchoko | Apr 26, 2024 | Portfolio Company News

Origionally posted on TTI’s website: https://tti.care/wilmot-cancer-institute-tti-study-presented-ons/   Selected for oral abstract presentation at the 2024 Oncology Nursing Society (ONS) Congress, promoting excellence in oncology nursing and the...
Patient Risk Management Platform Wave Health, Delivers Rare 93% Patient Compliance and 98% HCP Perceived Usefullness

Patient Risk Management Platform Wave Health, Delivers Rare 93% Patient Compliance and 98% HCP Perceived Usefullness

by Xcellerant Ventures | Jan 25, 2024 | Portfolio Company News

Origionally posted on TTI’s website: https://tti.care/patient-risk-management-platform-wave-health-delivers-rare-93-patient-compliance-and-98-hcp-perceived-usefulness/   Presented at the 2024 ASCO Genitourinary Cancers Symposium, PRO-WAVE1 Research Results...
Wave Health: Using Data & Technology to Improve Oncology Patient Care

Wave Health: Using Data & Technology to Improve Oncology Patient Care

by Xcellerant Ventures | Jun 9, 2023 | Portfolio Company News

Content origionally posted in NCODA spring 2023 magazine: https://www.ncoda.org/inspire/#24 It takes a village to overcome cancer. While oncology patients have always relied on networks of caregivers, oncologists, nurses, pharmacists, and the manufacturers of their...
New Data from Immunotherapy Quality of Life Study Accepted for Two Abstracts at 2023 ASCO

New Data from Immunotherapy Quality of Life Study Accepted for Two Abstracts at 2023 ASCO

by Xcellerant Ventures | Jun 2, 2023 | Portfolio Company News

Content origionally on TTI’s website: https://tti.care/new-data-from-immunotherapy-quality-of-life-study-accepted-for-two-abstracts-at-2023-asco/ — Treatment Technologies & Insights’ (TTI) ePRO app solution, Wave Health, enabled innovative approach to...
« Older Entries
Next Entries »

Recent Posts

  • Democratizing health care: There’s an app for that
  • Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
  • DeepLook Medical Expands Precision Imaging Capabilities Through Strategic Partnerships and Expert Advisors, Integrating Innovative Solutions into Widely Used Platforms to Deliver Critical Insights at
  • DeepLook Medical and NHS Oxford University UK announce new study
  • Scottsdale’s Xcellerant Ventures Launches Jetstream Venture Fund, Expanding Access to VC-Style Investing

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023